CCO Sheldon Aberman Reveals What Makes Chemistree Technology A Foremost Player In The Blossoming U.S. Cannabis Industry
We’re thrilled that we had the opportunity to sit down with Mr. Sheldon Aberman, the Chief Cannabis Officer of Chemistree Technology Inc. (CA:CHM – $0.67 & US:CHMJF – $0.50 & GER:CM1 – €0.44), a U.S. focused cannabis investment company.
Mr. Aberman first introduces Chemistree’s management team. He describes the backgrounds of some of the Company’s key players, such as Nico Escondido, Justin Chorbajian, and Dennis Hunter, all of whom are very well know and have decades of experience in the cannabis sector.
Next, the CCO provides insightful details about the Company’s initial acquisition in Washington State. He explains that Chemistree is already generating revenues through those operations and growth prospects are outstanding.
The executive also talks about the 9.55 acres of raw land that they acquired in the State of California, the biggest cannabis market in the world. The Company has secured financing to start construction of its 68,000 square foot greenhouse, which is expected to be completed early 2020 and contributing $20 million to the bottom line in that same year.
Mr. Aberman furthermore shares in which regions in the United States the Company is looking to further expand its activities. As such, he mentions New Jersey, the eastern seaboard, and the State of Maryland.
He concludes that investors can expect several large scale merger and acquisition deals from Chemistree in the coming quarters. If some of those transactions are closed successfully, he foresees revenues to be north of $10 million in 2019 and projects 2020 revenues in excess of $30 million. Smallcaps recommendation: BUY.
Access our interview by clicking the play button on the media player below,
or download our convenient transcript.
| For important disclosures, please read our disclaimer. | Latest Company Report (pdf) | |